NEW YORK (GenomeWeb) – Hologic reported after the close of the market on Wednesday that its third quarter revenues rose 12 percent year over year, crediting its molecular diagnostics and international businesses as drivers of new growth.

For the three months ended July 1, the firm reported total revenues of $806.1 million, up from $717.4 million in Q3 2016, and beating the average Wall Street analyst estimate of $799.7 million. On a constant-currency basis, revenues increased 13 percent.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.